Singapore: Patient recruitment in phase II CALM trial has accelerated significantly in the past three months with 25 pa...
Singapore: AtCor Medical, developer and marketer of the SphygmoCor system which measures central aortic blood pressures ...
Bangalore: The Association for the Accreditation of Human Research Protection Programs, announced that it has accredit...
Bangalore: RCC Laboratories, a Hyderabad based contract research organization (CRO) and ViruSure entered into a partners...
Singapore: Quintiles and dabl, a provider of centralized ambulatory blood pressure measurement (ABPM) services, have en...
Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the sa...
Singapore: China-based WuXiPRA, a contract research organization (CRO), has appointed Mr James Pusey, as president and g...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International, ha...
Singapore: Trifecta Clinical joined the board of directors for the Asia Training Consortium (ATC), which is a group of ...
What are the major issues confronting India's bioscience sector now? On top of every one's mind is the uncertainty over ...
Singapore: Swiss drugmaker Roche announced that it has started late-stage trials of its experimental drug, Lampalizumab....
Singapore: PharmaNet/i3, inVentiv Health's clinical segment, and a leading provider of clinical development services to ...
Clinical trial is a process which involves testing of efficacy of drugs for the purpose of determination of safety, prop...
Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Autho...
Singapore, June 8, 2012: Global clinical supply chain service provider, Marken has opened its first office in South Kore...
RedHill Biopharma Ltd., a specialty biopharmaceutical company primarily focused on the development and commercialization...
Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, announce...
